A high prevalence of a low glomerular filtration rate (GFR) has recently been reported in patients with diabetes without albuminuria. We aimed to clarify the clinical characteristics of such patients, including the associations between these characteristics and atherosclerosis. Methods: We investigated the correlations between the estimated GFR (eGFR) and lipid profiles, the ankle-brachial index (ABI) and the intima-media thickness (IMT) in 450 patients with type 2 diabetes without macroalbuminuria. Results: The prevalence of renal insufficiency (RI) (GFR ＜60 mL/min/1.73 m 2 ) in the patients without albuminuria was 19.1%. The ABI values of the patients with RI were significantly lower than those of the patients without RI, regardless of the presence of microalbuminuria, while there were no significant differences in IMT between the patients with and without RI. In a multivariate analysis, a low ABI was found to be significantly associated with a low eGFR, independent of age, sex, smoking, history of hypertension and/or dyslipidemia and duration of diabetes (β=0.134, p = 0.013), whereas no significant associations were observed between the ABI and the urinary albumin excretion rate (UAER). The ApoB/LDL-C ratios and levels of ApoC3 were significantly higher in the patients with RI than those observed in the patients without RI, regardless of the presence of albuminuria. Conclusions: RI without albuminuria is closely associated with atherosclerosis of the peripheral arteries in diabetic patients. Furthermore, alterations in lipid metabolism may underlie this association. 
Introduction
Diabetic nephropathy is a strong risk factor for cardiovascular disease and early mortality 1, 2) as well as end-stage renal disease (ESRD). The first clinical sign of classic diabetic nephropathy is the development of microalbuminuria, which gradually leads to macroalbuminuria, a decreased glomerular filtration rate (GFR) and finally ESRD. Therefore, microalbuminuria is considered to be an early marker for the detection of advanced diabetic nephropathy, another precursor of ESRD. However, several recent studies have found low GFR values in some patients with type 2 diabetes without macroalbuminuria [3] [4] [5] . For example, the Japan Diabetes Clinical Data Management Study Group (JDDM), which consists of general practitioners conducting research in the context of standard clinical practice, reported that the percentage of patients with diabetes and normoalbuminuric renal insufficiency (RI) is 12.3% 3) . Therefore, in patients with type 2 diabetes, diabetic nephropathy may have two clinical courses. Diabetic nephropathy can lead to a decreased GFR with or without macroalbuminuria. 
Analytical Methods
The UAER was determined using one 24-hour urine collection during hospitalization. Blood samples were obtained after a 12-hour fast to measure the levels of fasting blood sugar (FBS), HbA1c, total cholesterol (TC), TG, HDL-C, ApoA1, ApoA2, ApoB, ApoC2, ApoC3, ApoE, Lp(a) and creatinine. The level of HbA1c (%) was estimated as the NGSP equivalent value (%), calculated as HbA1c (%) = HbA1c (JDS) (%) ＋0.3% if HbA1c (JDS) ＜5, ＋0.4% if 5 ≤ HbA1c (JDS) ＜10, or ＋0.5% if 10 ≤ HbA1c (JDS), based on the relationship between the HbA1c (JDS) (%) measured according to the previous Japanese standard substance and measurement methods and the HbA1c (NGSP) 13) . The ABI was calculated using the higher of two systolic blood pressure (SBP) measurements obtained for each lower extremity divided by the higher of two SBP measurements for each upper extremity. The SBP was measured manually. The lowest ABI obtained for each patient was used in the subsequent statistical analyses.
The presence of CAD was defined as a physician's diagnosis of past myocardial infarction or angina pectoris or a history of coronary intervention. Stroke was defined as a brain infarction with or without symptoms, a transient ischemic attack or brain hemorrhage. The presence of PAD was defined as an ABI of ≤ 0.90 or ＞1.30. Overweight was defined as a BMI of ≥ 25.0 kg/m 2 . Smoking was categorized as never, past or current. Smokers who had quit smoking within the past five years were considered current smokers. Hypertension was defined as a SBP of ＞140 mmHg or a diastolic blood pressure (DBP) of ＞90 mmHg or both and/or the use of antihypertensive medications. Dyslipidemia was defined as a serum TC level of ＞220 mg/dL, a TG level of ＞150 mg/dL, an HDL-C level of ＜40 mg/dL or the use of lipid-lowering agents. RI, i.e., a low eGFR, was defined as an eGFR of ＜60 mL/ min/1.73 m 2 . Normoalbuminuria (NA) was defined as a UAER of ＜30 mg/g Cr, and microalbuminuria (MA) was defined as a UAER of ≥ 30 mg/g Cr.
The study subjects were divided into four groups: NA (RI−) with a UAER ＜ of 30 mg/g Cr and an eGFR of ≥ 60 mL/min/1.73 m 2 ; MA (RI−) with 30 ≤ UAER ＜300 mg/g Cr and an eGFR of ≥ 60 mL/ characteristics of normo-and microalbuminuric patients with a low GFR remain unclear.
Recent epidemiological studies have demonstrated that chronic kidney disease (CKD), defined as an eGFR of ＜60 mL/min, is an independent risk factor for atherosclerotic diseases, such as coronary artery disease (CAD) and cerebral vascular disease (CVD) 6, 7) . Furthermore, it has been reported that a high resistance index of the interlobular arteries is associated with a low GFR 8) . These reports indicate that atherosclerosis is more closely associated with the progression of RI than albuminuria. To test this hypothesis, we investigated the correlation between the renal function and atherosclerotic markers (ankle-brachial index [ABI] and intima-media thickness [IMT]) in patients with or without albuminuria.
Dyslipidemia is an important risk factor for atherosclerotic disease, even in patients with CKD 9, 10) . Previous studies have demonstrated that dyslipidemia is also a risk factor for renal disease. The Atherosclerosis Risk Communities study demonstrated that a high level of triglycerides (TGs) and a low level of highdensity lipoprotein cholesterol (HDL-C) are associated with an increased risk of developing renal insufficiency 11) . The Framingham Offspring Study also demonstrated that a low HDL-C level is an independent risk factor for incident CKD, defined as a GFR of ＜60 mL/min/1.73 m 2 12) . Therefore, we further investigated the associations between the lipid profiles and the renal function.
Methods

Study Subjects
A total of 513 consecutive patients with type 2 diabetes mellitus were hospitalized for glycemic control at the Department of Endocrinology and Metabolism of the National Cerebral and Cardiovascular Center between January 2005 and November 2009. Type 2 diabetes was diagnosed according to the Japanese Diabetes Society (JDS) criteria, i.e., a fasting blood glucose level of ≥ 126 mg/dL or a casual blood glucose level of ≥ 200 mg/dL, and usually not treated with insulin during the first year after diagnosis. Sixtythree patients with macroalbuminuria, defined as a UAER of ≥ 300 mg/g Cr, or who were receiving maintenance dialysis were excluded from the study. Finally, a cross-sectional study was performed with a population of 450 consecutive patients (304 men, mean age: 67.4±9.5 years) with type 2 diabetes mellitus. This study was conducted with the approval of the National Cerebral and Cardiovascular Center Trust Ethics Committee.
excluded from the statistical analysis.
Results
The NA (RI＋) patients constituted 19.1% (86/ 450) of all patients ( Table 1) . The NA (RI＋) patients had a higher prevalence of dyslipidemia than both the NA (RI−) and MA (RI−) patients. There were no significant differences in sex, HbA1c, SBP or smoking between these two groups. There were no significant differences in urinary β2 microglobulin (β2MG) excretion between the NA (RI＋) and MA (RI−) patients, although the MA (RI＋) patients had significantly higher levels of β2MG excretion than the patients in the other three groups ( Table 1) . There were no significant differences in the prevalence of retinopathy between the NA (RI＋) and MA (RI−) patients ( Table 1 
Statistical Methods
The results are presented as the mean±SD. Differences between groups were compared using the chisquared test for categorical variables and unpaired Student's t -test for continuous variables. Two-tailed p＜ 0.05 was considered to be statistically significant. A univariate analysis and multiple logistic regression analysis were performed to investigate the relationship between eGFR and ABI, age, sex, duration of diabetes, smoking, HbA1c, history of hypertension, history of dyslipidemia and angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) use. Patients with an ABI of ＞1.30 were Abbreviations: renal insufficiency (RI), normoalbuminuria (NA), microalbuminuria (MA), estimated glomerular filtration rate (eGFR), urinary albumin excretion rate (UAER), angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), coronary artery disease (CAD), cerebral vascular disease (CVD), peripheral artery disease (PAD) the NA (RI−) and NA (RI＋) patients (Fig. 1B) .
In the univariate analysis, the ABI was found to be significantly associated with the eGFR, whereas the UAER was not associated with the ABI (Fig. 2) . A multiple regression analysis showed that the ABI was significantly associated with the eGFR, independent of age, sex, duration of diabetes, smoking, HbA1c, history of hypertension and history of dyslipidemia, whereas the UAER was not associated with the ABI (Table 3) . Furthermore, there was a significant association between the ABI and the eGFR in a multivariate analysis that included ACEI and ARB use, in which the GFR decreased concomitantly with the UAER (Table 3) .
Discussion
Evidence has been accumulating that CKD, which presents as renal dysfunction, persistent albuminuria or both, is a strong risk factor for cardiovascular diseases, such as CAD, PAD and CVD. However, it remains unclear how significantly the type of renal dysfunction, that is albuminuria or RI, contributes to atherosclerotic diseases. In the present study of diabetic patients, we demonstrated that RI is significantly associated with ABI but not IMT, whereas albuminuria is significantly associated with IMT but not ABI.
The clinical course of typical diabetic nephropathy includes the development of microalbuminuria (RI＋) patients was significantly higher than that observed in the NA (RI−) patients ( Table 1) . On the other hand, the prevalence of CVD in the MA (RI−) and MA (RI＋) patients was higher than that observed in the NA (RI−) and NA (RI＋) patients ( Table 1) . There were no significant differences in the frequency of ACEI and ARB use between the NA (RI＋) and MA (RI−) patients. The MA (RI＋) patients had a higher frequency of ACEI and ARB use than the patients in the other three groups.
The levels of TGs in the NA (RI＋) and MA (RI＋) patients were significantly higher than those observed in the NA (RI−) and MA (RI−) patients ( Table 2 ). The levels of HDL-C in the NA (RI＋) and MA (RI＋) patients were significantly lower than those observed in the NA (RI−) and MA (RI−) patients ( Table 2 ). The NA (RI＋) and MA (RI＋) patients had significantly higher ApoB/LDL-C ratios than the NA (RI−) and MA (RI−) patients ( Table 2 ). The levels of Lp(a) in the MA (RI＋) patients were significantly higher than those observed in the NA (RI−) patients ( Table 2 ). The patients with RI had significantly higher ApoC3 levels than the patients without RI, regardless of the presence of albuminuria ( Table 2) .
The NA (RI＋) and MA (RI＋) patients had significantly lower ABI values than the NA (RI−) and MA (RI−) patients (Fig. 1A) . On the other hand, the MA (RI−) and MA (RI＋) patients had significantly higher IMT values than the NA (RI−) patients, whereas there were no significant differences in IMT between progressing to overt proteinuria and a decline in GFR. However, several reports have demonstrated that RI occurs in some patients with normoalbuminuria 3) . The histological characteristics of diabetic nephropathy include mesangial matrix accumulation, podocyte loss and glomerular basement membrane thickening. These glomerular injuries cause albuminuria. However, the diabetic kidney also experiences tubulointerstitial injury and vascular changes in addition to glomerular injury. Interstitial fibrosis, which is common even during the early stages of diabetic nephropathy with mild glomerular changes 15) , leads to a decline in GFR 16) . Furthermore, since the arteries in the diabetic kidney invariably exhibit typical atherosclerotic changes 17) , the diabetic kidney is at risk of ischemic damage. Indeed, in a study of 393 renal biopsy samples obtained from patients with type 2 diabetes 18) , 15% primarily demonstrated ischemic changes. Therefore, it has also been suggested that interstitial fibrosis and ischemic vascular disease contribute to renal injury in patients with type 2 diabetes, especially those with RI without albuminuria. In this study, a low ABI, reflecting atherosclerosis of the peripheral arteries, was associated with RI. An epidemiological study also demonstrated that the GFR is associated with large artery elasticity 19) . MacIsaac et al. reported that a In this study, RI, but not albuminuria, was found to be significantly associated with lipid metabolism abnormalities. Compared to the patients without RI, those with RI had high ApoB/LDL-C ratios, indicating the existence of small, dense LDL-C particles 23) . This form of LDL-C is strongly atherogenic. Indeed, a clinical study demonstrated that small, dense LDL-C is an independent risk factor for cardiovascular disease 24) . ApoB has also been reported to be a predictor of renal failure progression 25) , suggesting that small, dense LDL-C is involved in the progression of renal injury as well as cardiovascular disease. We also demonstrated high Apo C3 levels in the patients with RI compared to those observed in the patients without RI. Since ApoC3 is a well-known endogenous lipoprotein lipase (LPL) inhibitor 26) , our data suggest that the LPL activity, which contributes to increases in small, dense LDL-C, may be lower in patients with diabetes and RI. ApoC3 has also been reported to directly activate vascular endothelial cells via the activation of protein kinase C β 27) . Therefore, an elevation of the ApoC3 level is considered to play a role in the progression of atherosclerosis. It has also been suggested that a high level of ApoC3 is involved in renal injury via atherosclerosis of the intrarenal arteries. Moreover, several clinical trials have demonstrated that statin therapy can prevent declines in GFR 25, 28, 29) . These reports indicate that amelioration of dyslipidemia contributes to the prevention of renal function deterioration. Altogether, atherogenic dyslipidemia may be associated with a declining GFR as well as cardiovascular disease progression in patients with diabetes.
Another possible mechanism underlying the association between RI and dyslipidemia is the direct alteration of lipid metabolism by RI. Renal failure impacts lipid metabolism via impaired carbohydrate tolerance as well as a decreased LPL activity due to endogenous LPL inhibition involving pre-β-HDL accumulation and insulin resistance 30) . In this study, however, the contribution of RI to abnormalities in high resistance index of the interlobular arteries is associated with a low GFR 8) , thus suggesting that a decline in eGFR may be caused by atherosclerosis of the intrarenal arteries. These results as well as the present findings indicate the possibility that patients with peripheral artery atherosclerosis may also have intrarenal atherosclerosis that causes RI without albuminuria.
Since the IMT reflects early atherosclerotic changes, an increased IMT is expected to be associated with both albuminuria and low-grade RI. Indeed, in this study, the IMT values of the patients with albuminuria were significantly higher than those of the NA (RI−) patients. However, there were no significant differences in IMT between the NA (RI＋) and NA (RI−) patients, even though the NA (RI＋) patients had lower ABI values. The Dong-gu study showed that a low eGFR, but not IMT, is associated with carotid plaque 20) . That report also demonstrated that a low eGFR is associated with PAD 20) . Taken together, these findings suggest that the mechanism of atherosclerosis observed in NA (RI＋) patients is similar to that of plaque formation and a lower ABI, rather than intima-media thickening.
In this study, the UAER was not significantly associated with the ABI. Previous reports indicate that the UAER is closely associated with early atherosclerotic markers, such as endothelial dysfunction and IMT 20, 21) . On the other hand, decreases in ABI may reflect relatively advanced atherosclerosis since a decreased ABI indicates the presence of peripheral artery stenosis.
Our findings demonstrate albuminuria to be significantly associated with cerebrovascular disease. Ito et al. proposed that albuminuria may be an early marker of strain vessel injury. The arterioles in the kidneys are relatively similar to the perforating arteries in the brain 22) . Indeed, it has been reported that albuminuria is associated with decreased small artery elasticity 19) . lipid metabolism were relatively minimal because the number of patients with severe renal dysfunction (eGFR ＜30 mL/min) was small (41/513), especially among the patients with normoalbuminuria (7/305).
Our study is associated with several limitations. First, we used a cross-sectional analysis; therefore, a prospective study is needed to clarify whether RI without albuminuria increases the risk of CAD and PAD. Second, the number of participants was relatively small in epidemiological terms, suggesting that there may not have been a sufficient number of patients representing the whole range of the renal function. Third, the UAER was measured using only one urine sample in this study. Therefore, the evaluation of UAER performed in this study may be inaccurate compared to that observed in studies with two or three measurements, which is common practice. Fourth, it is possible that not all cases of asymptomatic CAD and CVD were detected since CT examinations and exercise electrocardiograms were not performed in all patients. Fifth, renal injury can be induced by contrast media in patients with CAD who have undergone coronary angiography. Therefore, we cannot rule out the possibility that the patients with RI had contrast nephropathy. Sixth, since we studied patients who were hospitalized for glycemic control, it is possible that the HbA1c levels were overestimated.
In conclusion, we demonstrated that RI without albuminuria is closely associated with peripheral artery atherosclerosis, thereby highlighting the importance of clinical screening of CAD and PAD in NA (RI＋) patients. Furthermore, we demonstrated that the ApoB/LDL-C ratios and ApoC3 levels are significantly higher in patients with RI, thus suggesting that atherogenic dyslipidemia may underlie the association between RI and cardiovascular disease in patients with diabetes.
Conflicts of Interest
None to declare.
